TREM2c·3G>A promotes aberrant microglial-endothelial signaling, impairs BBB integrity, and enhances Aβ and Tau accumulation
Year: 2026
Type: article
Abstract: We identified a novel start-codon mutation in TREM2 ( TREM2 c·3G>A , M1I) that causes complete loss of TREM2 expression and is associated with early-onset Alzheimer’s disease (AD) in humans. This mutation triggers profound blood-brain barrier (BBB) impairment in both humans and mice, positioning BBB impairment as an early trigger rather than a downstream consequence of neurodegeneration in AD. Mechanistically, TREM2 deficiency causes NF-κB-driven upregulation of microglial CCL2, which activates CCR2 on endothelial cells and induces tight junction internalization. The resulting BBB compromise permits the leakage of peripheral pathological proteins, including β2-microglobulin, accelerating amyloid plaque formation and premature Tau pathology. Pharmacological inhibition of CCR2 and endothelial cell-specific Ccr2 knockdown restored BBB function and reduced amyloid plaque burden, highlighting this pathway as a tractable therapeutic target. Our findings establish a direct mechanistic link between microglial dysfunction, BBB breakdown, and pathogenic protein accumulation, thereby redefining the vascular role of TREM2 in neurodegenerative disease.
Source: Molecular Neurodegeneration
Authors: Han-Chen Yang, Christabel Xin Tan, Ouyang Chen, Jing Zhang, Yu-Sen Deng, Zhibin Wang, Liwei Sun, Ye Liang, Yusheng Wei, Yunsi Yin, Yuhang Zhang, Bao-Dong He, Rui-Yang Li, Run Di, Chuheng Jiang, Meng Wang, Zhi-Qing David Xu, Chang-Mei Liu, Yi Xing, Chunlin Li, Qi Qin, Zhao-Qian Teng, Yi Tang
Institutions: Capital Medical University, Chinese Academy of Sciences, Xuan Wu Hospital of the Capital Medical University, Chinese Institute for Brain Research, Institute of Zoology, State Key Laboratory of Stem Cell and Reproductive Biology, University of Michigan, Peking University, State Key Laboratory of Membrane Biology, Beijing Institute for Brain Disorders
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,090
OpenAlex ID: W7225983379
